SynthesisInflammopharmacology2025
Effects of Nigella sativa and its constituents on inflammatory markers in ovalbumin-induced asthma model: a preclinical systematic review and meta-analysis.
Synthesis in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResearch demonstrates that Nigella sativa (N. sativa) and its principal constituents, including thymoquinone, thymol, carvacrol, and α-hederin, possess anti-inflammatory, antioxidant, and immunomodulatory properties. This meta-analysis aims to evaluate the preclinical evidence of N. sativa in an animal model of ovalbumin-induced asthma.
methodsAn investigation into the role of N. sativa and its constituents in an animal model of ovalbumin-induced asthma was conducted, covering the period from the beginning until July 2025, utilizing the Scopus, PubMed, and Web of Science databases. The methodological quality of the studies was evaluated using the 15-point CAMARADES checklist. Data analysis was performed using STATA software.
resultsA total of eighteen studies encompassing 502 animals, with 251 assigned to the intervention group and 251 to the ovalbumin-induced group, were subjected to analysis. The findings from the meta-analysis indicated that N. sativa and its constituents significantly reduced the levels of interleukin (IL)-4, IL-5, IL-13, and IL-17. Furthermore, there was a notable decrease in immunoglobulin E (IgE) following the intervention with N. sativa and its active components. However, the levels of interferon-gamma (IFN-γ) remained unchanged as a result of the intervention with N. sativa and its active ingredients.
conclusionBased on current meta-analysis results, N. sativa and its constituents may have the potential to modulate the asthma model induced by ovalbumin through their anti-inflammatory and antioxidant effects. Therefore, it is advisable to conduct further clinical trials to assess the efficacy of N. sativa in patients diagnosed with asthma.
Indexed as
Identifiers
40839182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.